EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

An Update of Immunohistochemistry in Hepatocellular Carcinoma

Bingyu Li iD, Larry Huang, Jialing Huang, Jianhong Li iD

Diagnostics · 25.08.2025 · 15 (17) · 2144

DOI: 10.3390/diagnostics15172144 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 25.08.2025. Verfasst von Bingyu Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Icahn School of Medicine at Mount Sinai-Morningside/West, New York City, NY 10019, USA. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) remains a global health challenge due to molecular heterogeneity and frequent delayed diagnosis. This comprehensive review synthesizes recent immunohistochemistry (IHC) advancements for HCC diagnosis, prognostication, and therapeutic prediction. We systematically evaluate conventional markers, such as hepatocyte paraffin 1 (HepPar1), arginase-1 (Arg-1), and glypican-3 (GPC3), as well as emerging biomarkers, detailing their diagnostic sensitivities and specificities in HCC with varied tumor differentiation. Prognostic immunostaining markers, such as Ki-67 proliferation index and vascular endothelial growth factor (VEGF) overexpression, correlate with reduced 5-year survival, while novel immune checkpoint IHC markers (PD-L1 and CTLA-4) predict response to immunotherapy, particularly in advanced HCC. This work provides evidence-based recommendations for optimizing IHC utilization in clinical practice while identifying knowledge gaps in biomarker validation and standardization.

Schlagwörter

Stichwörter der Autor:innen

diagnostic biomarkershepatocellular carcinoma (HCC)immunohistochemistry (IHC)predictive biomarkersprognostic markers

Autor:innen und Institutionen

  • Department of Pathology, Icahn School of Medicine at Mount Sinai-Morningside/West, New York City, NY 10019, USA.
  • College of Arts and Sciences, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Department of Pathology, Geisinger Medical Center, Danville, PA 17822, USA.

ORCID-Profile: Bingyu Li, Jianhong Li

Zitieren

APA

Li, B., Huang, L., Huang, J., & Li, J. (2025). An Update of Immunohistochemistry in Hepatocellular Carcinoma. Diagnostics, 15(17), 2144. https://doi.org/10.3390/diagnostics15172144

Vancouver

Li B, Huang L, Huang J, Li J. An Update of Immunohistochemistry in Hepatocellular Carcinoma. Diagnostics. 2025;15(17):2144. doi:10.3390/diagnostics15172144

BibTeX
@article{Li2025,
  author = {Li, Bingyu and Huang, Larry and Huang, Jialing and Li, Jianhong},
  title = {An Update of Immunohistochemistry in Hepatocellular Carcinoma},
  journal = {Diagnostics},
  year = {2025},
  volume = {15},
  number = {17},
  pages = {2144},
  doi = {10.3390/diagnostics15172144}
}
Kostenlos starten →